Form 4: Streamline Health Solutions CFO Receives 150,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Bryant J. Reeves III, CFO of Streamline Health Solutions, was granted 150,000 shares of restricted stock on April 29, 2024, which will vest in three equal installments assuming continued employment.

Summary

  • Bryant J. Reeves III, the Chief Financial Officer of Streamline Health Solutions Inc., received 150,000 shares of restricted stock on April 29, 2024.
  • The shares were granted as part of his compensation package.
  • The restricted stock will vest in three substantially equal installments on April 29, 2025, April 29, 2026, and April 29, 2027, contingent upon continued employment with the company.
  • Following the transaction, Reeves directly owns 229,418 shares of Streamline Health Solutions Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of restricted stock is a common practice and indicates confidence in the executive's continued service. It's a routine filing, but positive for aligning management with shareholder interests.

Positives

  • The grant of restricted stock aligns the CFO's interests with the long-term performance of the company.
  • Continued employment is required for vesting, incentivizing the CFO to remain with the company.

Industry Context

Equity compensation, including restricted stock grants, is a common practice in the healthcare technology industry to attract and retain key executives.

Comparison to Industry Standards

  • Many companies in the healthcare technology sector, such as Cerner (now Oracle Health) and Allscripts, utilize restricted stock units (RSUs) as part of their executive compensation packages.
  • The vesting schedules for these RSUs typically range from three to five years, aligning with the long-term strategic goals of the company.
  • The amount of equity granted to executives is often benchmarked against peer companies of similar size and market capitalization.

Stakeholder Impact

  • Shareholders may view the grant positively as it aligns management's interests with the company's long-term success.
  • Employees may see this as a sign of stability and commitment from the company to its leadership.

Key Dates

DateDescription
04/29/2024Date of transaction: Grant of 150,000 shares of restricted stock.
04/29/2025First vesting date for restricted stock (one-third of the shares).
04/29/2026Second vesting date for restricted stock (one-third of the shares).
04/29/2027Final vesting date for restricted stock (one-third of the shares).
05/01/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.